Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications
- 1 October 2014
- journal article
- review article
- Published by Elsevier BV in Neurotherapeutics
- Vol. 11 (4), 738-750
- https://doi.org/10.1007/s13311-014-0284-z
Abstract
No abstract availableKeywords
This publication has 175 references indexed in Scilit:
- Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding ActivitiesJournal of Molecular Biology, 2011
- Translation Initiator EIF4G1 Mutations in Familial Parkinson DiseaseAmerican Journal of Human Genetics, 2011
- A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson DiseaseAmerican Journal of Human Genetics, 2011
- VPS35 Mutations in Parkinson DiseaseAmerican Journal of Human Genetics, 2011
- Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's diseaseMovement Disorders, 2010
- The R1441C mutation alters the folding properties of the ROC domain of LRRK2Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- The Parkinson’s disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sitesBiochemical and Biophysical Research Communications, 2009
- Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2Biochemical and Biophysical Research Communications, 2009
- The Roc domain of leucine‐rich repeat kinase 2 is sufficient for interaction with microtubulesJournal of Neuroscience Research, 2008
- The R1441C mutation of LRRK2 disrupts GTP hydrolysisBiochemical and Biophysical Research Communications, 2007